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Type 1 diabetes mellitus
TreatmentAims: This study aimed to evaluate the impact of diabetes education and access to
healthcare coverage on disease management and outcomes in Latin America.
Methods: Data were obtained from a sub-analysis of 2693 patients with type 1 diabetes mel-
litus recruited from 9 Latin American countries as part of the International Diabetes Melli-
tus Practices Study (IDMPS), a multinational, observational survey of diabetes treatment in
developing regions.
Results: Results from the Latin American cohort show that only 25% of participants met
HbA1c target value (< 7% [53 mmol/mol]). Attainment of this target was significantly higher
among participants who had received diabetes education than those who hadn’t (28% vs.
19%, p < 0.001), and among those who practiced self-management (27% vs. 21% no self-
management, p = 0.001). Multivariate analysis showed that participants who had received
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Conclusions: Given the association between uncontrolled diabetes and long-term complica-
tions, health authorities and care providers should increase efforts to ensure widespread
healthcare coverage and access to self-management education to reduce the socioeco-
nomic and humanistic burden of type 1 diabetes.
 2018 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Care for people with diabetes and its chronic complications
represents a substantial social and economic burden for
national healthcare systems and society overall [1]. Health-
care systems in Latin America face the challenge of increas-
ing prevalence of chronic diseases such as diabetes and
hypertension without a parallel growth of their budget [2].
In 2013, care for adults with diabetes in South and Central
America accounted for approximately 13% of total healthcare
expenditure [3]. In order to optimize the use of finite
resources, a shift towards preventative medicine is required
[2].
Within the last decade, most Latin American countries
have introduced new schemes of universal health insurance
which have substantially improved access to healthcare ser-
vices [2]. Despite these schemes, the quality of diabetes care
in Latin America remains suboptimal. Many patients were
not monitored for risk factors and complications at the rec-
ommended intervals while fasting blood glucose, HbA1c,
triglyceride and cholesterol levels are generally outside target
ranges [4]. Furthermore, access to insulin in the region is
often limited and, even when available, it is not always pre-
scribed and used appropriately, and most patients do not
meet glycemic targets [5].
Care for people with type 1 diabetes mellitus (T1DM) pre-
sents a particular challenge since the provision of multidisci-
plinary care, essential for management of this complex
disease, is scarce in Latin America [5]. Effective control of
T1DM requires patients’ active participation in making day-
to-day decisions related to the control and treatment of their
disease. In order to do so effectively, they need to understand
how to adjust their insulin doses in response to self-
measured blood glucose levels, carbohydrate intake, exercise
load and illness. It has been shown that diabetes education is
the most appropriate strategy to promote effective self-
management [6,7]. Several reports have demonstrated the
beneficial effect of education for people with type 2 diabetes
mellitus (T2DM) in Latin America [8–10] but data are scarce
for T1DM.
In order to address this lack of information, we have ana-
lyzed data from the Latin American cohort of the Interna-
tional Diabetes Mellitus Practices Study (IDMPS). Since 2005,
the International Diabetes Mellitus Practices Study (IDMPS)
has been seeking to understand the challenges of managing
diabetes in the real world. IDMPS is the largest ever observa-
tional study program that describes patient profiles, manage-ment and patterns of care across time in developing regions,
and is conducted on a yearly basis in real-world settings.
Using data from these surveys, we have reported multidimen-
sional factors related to glycemic control including clinical
characteristics, healthcare coverage, care processes and
access to diabetes education [11]. Since its initiation in 2005,
we have conducted six waves, each within a 12-month period,
enrolling patients from diverse clinical settings. Data from
the first wave showed that people with T1DM were more
likely to attain HbA1c if they practiced self-monitoring of
blood glucose (SMBG) and had access to diabetes education
[11,12]. For the current analysis, we focused on people with
T1DM in Latin America from four successive waves and
explored associations between glycemic control and diabetes
education, self-management and healthcare coverage.2. Materials and methods
The design and objectives of the IDMPS study have been
described previously [11]. Briefly, IDMPS is an observational,
multinational study to assess the therapeutic management
of people with diabetes in real-world medical practice. The
study was conducted in six waves (Wave 1: 2005; Wave 2:
2006; Wave 3: 2008; Wave 4: 2010; Wave 5: 2011–12; Wave 6:
2013–14), each of which included a cross-sectional survey.
Data from the Latin American cohort, Waves 1–4, are reported
here.2.1. Study implementation
The study was coordinated by Sanofi-Diabetes Intercontinen-
tal and a steering committee of international diabetologists.
Ethics approval was obtained from institutional review boards
in each participating country and the study was conducted in
accordance with the Declaration of Helsinki. All participants
provided written informed consent.2.2. Selection of centers/physicians and sample size
estimation
Participating investigators included endocrinologists, dia-
betologists and general practitionerswith experience in initia-
tion and titration of insulin therapy [11]. Investigators/centers
for each study wave were selected independently and investi-
gators could participate in more than one wave. Sample sizes
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endpoint,whichwas to establish thepercentage of peoplewith
T2DM treated with insulin.
2.3. Participants
Physicians enrolled the first five adults (aged  18 years) with
T1DM and ten adult patients with T2DM who attended their
clinic during the 2-week recruitment period. Patients only
participated in one wave. Patients who were actively partici-
pating in another clinical study, or were receiving temporary
insulin treatment (e.g. for gestational diabetes or pancreatic
cancer) were excluded.
2.4. Data collection and outcome measures
Before each study wave, attributes of the participating inves-
tigator and center were recorded, including their specialist
status, years of experience, nature of healthcare organization
and medical coverage. All patient data were collected on case
report forms which included demographics, socio-economic
profile, types of diabetes, disease duration, co-existing com-
plications and cardiovascular risk factors, glycemic control,
history of hypoglycemia, frequency of physical activity, cur-
rent insulin treatment regimen. Patients’ attendance of dia-
betes education programs (including type and modality of
education received) and self-care practices (including SMBG
and insulin dose self-adjustment [ISA]) were also recorded.
Self-management was defined as practice of both SMBG and
ISA. Glycemic control target was defined as HbA1c < 7%
(53 mmol/mol).
2.5. Statistical analysis
Unless specified, data from all waves were pooled for analysis.
For variables with two modalities, Wilcoxon signed-rank
(quantitative variables) or Chi-squared (qualitative variables)
tests were used; for variables with more than two modalities,
Kruskal-Wallis (quantitative variables) or Fisher’s exact (qual-
itative variables) tests were used. Univariate and logistic
regression analyses were performed to identify predictive fac-
tors for: self-management, receipt of diabetes education and
glycemic control. For the logistic regression, age was divided
into three classes: < 40 years old, 40–64 years old and
 65 years old. Continuous variables included in the model
were: total daily insulin dose, time since diagnosis, time on
insulin treatment and waist circumference.
All predictors with a p-value < 0.20 in univariate analysis
were included in a logistic regression model. Then, a stepwise
procedure was used to select the most relevant model. Start-
ing from a full model with all independent variables selected
based on the univariate analysis, all non-significant variables
were removed one by one until all parameters reached a level
of significance of at least 0.05. Interactions between indepen-
dent variables were not considered. Odds ratios were pro-
vided with 95% confidence intervals.
In all data analyses, participants with missing data were
not considered when reporting proportions of participants
in categories described.3. Results
AcrossWaves 1–4, a total of 2693 participants with T1DMwere
recruited in Latin America (Table 1). Almost all participants
(96%) lived in an urban setting, and 70% were recruited by dia-
betes specialists. Most participants (56%) attended clinics that
cared for a mixture of public and private patients.
Of the patients recruited, 44% were male, with a mean age
of 38 years (standard deviation [SD]: 16 years). Mean time
since diagnosis of T1DM was 14.1 years (SD: 10.7 years).
Almost half (48%) of the participants received university or
higher level education. Overall, 83% of participants were cov-
ered by health insurance.
Basal plus prandial insulin was the most frequently used
treatment regimen (65%) while 24% used basal insulin alone.
Approximately half (52%) of participants who used a basal
plus prandial regimen used analog insulin. Basal plus pran-
dial insulin regimen was more frequently used by partici-
pants with healthcare coverage than those without
insurance (68% vs. 53%, p < 0.001).
3.1. Diabetes education
The majority of patients (65%) had received diabetes educa-
tion, mainly on an individual basis. Attendance to diabetes
education was more common among participants recruited
by diabetes specialists than those recruited by a general prac-
titioner, (67% vs. 61%, p = 0.009) and among those with health
insurance (67% vs. 56% among those without insurance,
p < 0.001). Rates of diabetes education differed between coun-
tries with the highest rate reported in Chile (82%) and the low-
est in the Dominican Republic (29%, Table 1).
3.2. Diabetes self-management activities
Most participants (82%) performed SMBG, but only 63% prac-
ticed ISA while 58% of participants practiced both SMBG and
ISA (i.e. self-management). Rates of diabetes self-
management differed between countries with the highest
rate reported in Chile (84%) and the lowest in the Dominican
Republic (29%).
Self-management (SMBG + ISA) was more common among
participants who had received diabetes education (65% vs.
46% of participants without diabetes education, p < 0.001),
with health insurance (62% vs. 40% without insurance,
p < 0.001) and among those recruited by a diabetes specialist
(68% vs. 35% of participants recruited by a general practi-
tioner, p < 0.001).
3.3. Glycemic control
Overall, 25% of participants met HbA1c target (< 7%
[53 mmol/mol]) and 28% had HbA1c > 9% (75 mmol/mol).
Rates of HbA1c target attainment were similar in participants
managed by a specialist or a general practitioner (24.7% vs.
24.9%, respectively; p = 0.932). Target attainment was numer-
ically higher among participants with health insurance cover-
age than those without (26% vs. 21%, respectively; p = 0.061;
Fig. 1).
Table 1 – Participant baseline characteristics, overall and according to diabetes education.





n = 1735 (65%)
Not educated
n = 924 (35%)
Country, n (%) N = 2693 N = 1735 N = 924 < 0.001 (F)
Argentina 830 (31) 519 (64) 295 (36)
Chile 119 (4) 98 (82) 21 (18)
Colombia 450 (17) 345 (78) 98 (22)
Dominican Republic 49 (2) 14 (29) 34 (71)
Ecuador 30 (1) 24 (80) 6 (20)
Guatemala 55 (2) 30 (57) 23 (43)
Mexico 733 (27) 431 (59) 300 (41)
Panama 13 (1) 8 (62) 5 (38)
Venezuela 414 (15) 266 (65) 142 (35)
Ethnicity, n (%) N = 2287 N = 1473 N = 791 0.179 (F)
Caucasian 728 (32) 459 (31) 257 (33)
Native Latin 1492 (65) 961 (65) 520 (66)
Black 8 (< 1) 5 (< 1) 3 (< 1)
Japanese 2 (< 1) 2 (< 1) 0
Oriental, Arab, Persian 1 (< 1) 1 (< 1) 0
Other Asian 3 (< 1) 2 (< 1) 1 (< 1)
Other 53 (2) 43 (3) 10 (1)
Gender, n (%) N = 2625 N = 1697 N = 894
Male 1143 (44) 743 (44) 387 (43) 0.809 (C)
Mean age, years (SD) 37.7 (15.8) 36.7 (15.4) 39.4 (16.3) < 0.001 (W)
Mean time since diabetes diagnosis, years (SD) 14.1 (10.7) 14.5 (10.7) 13.3 (10.6) 0.002 (W)
Mean body mass index, kg/m2 (SD) 24.7 (4.5) 24.4 (4.1) 25.1 (5.1) 0.027 (W)
Physician specialty, n (%) N = 2536 N = 1647 N = 889 0.009 (C)
Diabetes specialist 1782 (70) 1186 (72) 596 (67)
General practitioner 754 (30) 461 (28) 293 (33)







Glycemic control, n (%) N = 2188 N = 1495 N = 688 < 0.001 (C)
HbA1c < 7% 546 (25) 412 (28) 128 (19)
Insulin regimen, n (%) N = 2602 N = 1670 N = 898 < 0.001 (C)
Basal alone 618 (24) 324 (19) 285 (32)
Basal + prandial 1701 (65) 1181 (71) 498 (54)
Prandial alone 39 (2) 31 (2) 8 (1)
Premix alone 172 (7) 94 (6) 76 (8)
Others 72 (3) 40 (2) 31 (3)
Mean number of daily injections by insulin regimen (SD) < 0.001 (C)
Basal alone 1.57 (0.55) 1.62 (0.52) 1.52 (0.57) 0.016 (W)
Basal + prandial 4.18 (0.97) 4.21 (0.97) 4.09 (1.00) 0.031 (W)
Prandial alone 2.42 (0.90) 2.46 (0.78) 2.33 (1.21) 0.853 (W)
Premix alone 2.10 (0.46) 2.12 (0.42) 2.08 (0.51) 0.610 (W)
Diabetes management strategy used, n (%)





















C, Chi-squared test; F, Fisher exact test; W, Wilcoxon test.
a Participants with missing data were not considered when reporting proportions of participants in categories listed.
b Data on diabetes education status were not available for 34 participants.
c Includes all patients who practice SMBG, some of whom are included among those who practice self-management.
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Fig. 1 – HbA1c percentage distribution according to health
insurance. NS, not significant.
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those with diabetes education (28% vs. 19% without diabetes
education, p < 0.001), and those who practiced self-
management (27% vs. 21% no self-management, p = 0.001).
Diabetes education was also important for effective self-
management practice. In those who practiced self-
management, the rate of HbA1c target attainment was
significantly higher among those who had also received
diabetes education than those who had not (30% vs. 22%,
respectively; p = 0.003). Conversely, HbA1c values > 9%
(75 mmol/mol) were significantly more frequently recorded
in participants without diabetes education than in those
who had received it (36% vs. 25%, respectively; p < 0.001).
3.4. Multivariate analysis
After controlling for confounders, lack of complications,
lower insulin dosage (< 1 unit/kg), receipt of diabetes educa-
tion and having a glucometer were independent predictors
for attaining HbA1c target (Fig. 2A). Predictors for diabetes
education included having a glucometer and seeing a special-
ist (Fig. 2B). Independent predictors for self-management
included younger age, higher education level, treatment with
basal-bolus regimen, long time since diagnosis, having pri-
vate medical insurance and access to diabetes education
and seeing a specialist (Fig. 2C). Odds ratios for these effect
sizes ranged from 1.1 to 1.82 for positive associations and
from 0.28 to 0.92 for negative associations (Fig. 2A–C).
4. Discussion
In this analysis of a large cohort of people with T1DM from
Latin America, we confirm the multidimensional nature of
factors determining attainment of HbA1c target; factors iden-
tified included insulin dosage, lack of complications, access to
diabetes education and to a glucometer: the latter being
essential tools for SMBG and ISA. Our analysis also highlights
a need to improve glycometabolic control for people with
T1DM in Latin America, since only 25% of participants
attained HbA1c target values (< 7.0% [53 mmol/mol]). Poor
metabolic control is associated with increased risk for the
development and progression of chronic complications of
T1DM [13–16] and a decrease in quality of life [17,18].Many studies have confirmed the utility of diabetes educa-
tion in empowering patients with T1DM to take effective con-
trol of their disease with clinical, metabolic and economic
benefits [19,20]. Based on this large body of evidence, wide-
spread implementation of diabetes education programs is
recommended by a number of national organizations
[20,21]. Supporting these recommendations, our data showed
that participants who had received diabetes education were
more likely to practice self-management and to attain HbA1c
values < 7% (53 mmol/mol), than those without education. In
the Middle East population of IDMPS, self-management was a
significant independent predictor of glycemic control [22].
This was not the case in the current study, though glucometer
availability was a predictor of glycemic control, and this was
also strongly linked with self-monitoring of blood glucose:
98% of patients who owned a glucometer practiced SMBG
comparedwith 1% of thosewithout a glucometer. Participants
who had received diabetes education were also more likely to
receive basal and prandial insulin, than those without who
most frequently received basal alone; the use of prandial
insulin only will likely be a barrier for the achievement of
HbA1c target.
In this Latin American population, HbA1c target attain-
ment was higher among participants with health insurance
coverage than in those without. Furthermore, participant
health insurance coverage was a significant independent pre-
dictor of self-management suggesting that costs associated
with diabetes care may deter people without insurance from
managing their diabetes and thus attaining appropriate gly-
cometabolic control. In fact, test strips for SMBG account for
a substantial proportion of overall diabetes care costs in Latin
America and attainment of HbA1c target was associated with
greater strip use [23]. Although there is strong evidence that
intensive treatment for people with T1DM is cost-effective
overall [24], self-management without appropriate diabetes
education can incur substantial costs (e.g. through increased
use of SMBG strips), without any improvement in metabolic
outcomes. This is illustrated by our finding that the rate of
target attainment in participants who practiced self-
management without diabetes education was similarly low
to the rate in participants who did not practice any self-
management (22% vs. 21%, respectively). Thus, diabetes edu-
cation may help patients to optimize their use of SMBG strips
and learn how to carry out ISA in order to maximize the cost-
effectiveness of self-management.
Participants recruited by diabetes specialists were more
likely to have received diabetes education than those
recruited by general practitioners. This indicates one of the
benefits of specialist care, and suggests that efforts may be
needed in the region to promote the importance of diabetes
education to general practitioners in the region.
In summary, these findings from Waves 1–4 in Latin Amer-
ica, and those reported previously from the IDMPS study for
other waves and regions, have proved the strong relationships
between diabetes education, self-management and attain-
ment of HbA1c target [11,22]. Our results suggest that health
authorities, policymakers, insurers, healthcare administra-
tors and providers should increase efforts to ensure wide-
spread healthcare coverage and access to education about
diabetes self-management in order to decrease the heavy
Fig. 2 – (A) Predictive factors for HbA1c target attainment. (B) Predictive factors for receipt of diabetes education. (C) Predictive
factors for diabetes self-management. *‘‘Others’’ includes any regimen other than Basal + Prandial, Basal alone, Prandial
alone or Premix alone. CI, confidence interval; OR, odds ratio.
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ety overall.
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